Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-1.75%
$94.73
2% positive prob.
5-Day Prediction
-2.26%
$94.23
2% positive prob.
20-Day Prediction
-1.38%
$95.08
2% positive prob.
SEC 8-K filings with transcript text
Feb 17, 2026 · 96% conf.
1D
-1.75%
$94.73
Act: +2.16%
5D
-2.26%
$94.23
Act: +0.35%
20D
-1.38%
$95.08
mdt-202602170001613103H91 VY19false00016131032026-02-172026-02-170001613103mdt:A1.125SeniorNotesDue2027Member2026-02-172026-02-170001613103mdt:A0.375SeniorNotesDue2028Member2026-02-172026-02-170001613103mdt:A3.000SeniorNotesDue2028Member2026-02-172026-02-170001613103mdt:A3.650SeniorNotesDue2029Member2026-02-172026-02-170001613103mdt:A2.950SeniorNotesDue2030Member2026-02-172026-02-170001613103mdt:A1.625SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A1.000SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A3.125SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A0.750SeniorNotesDue2032Member2026-02-172026-02-170001613103mdt:A3.375SeniorNotesDue2034Member2026-02-172026-02-170001613103mdt:A3.875SeniorNotesDue2036Member2026-02-172026-02-170001613103mdt:A2.250SeniorNotesDue2039Member2026-02-172026-02-170001613103mdt:A1.500SeniorNotesDue2039Member2026-02-172026-02-170001613103mdt:A1.375SeniorNotesDue2040Member2026-02-172026-02-170001613103mdt:A4.150SeniorNotesDue2043Member2026-02-172026-02-170001613103mdt:A4.200SeniorNotesDue2045Member2026-02-172026-02-170001613103mdt:A1.750SeniorNotesDue2049Member2026-02-172026-02-170001613103mdt:A1.625SeniorNotesDue2050Member2026-02-172026-02-170001613103mdt:A4.150SeniorNotesDue2053Member2026-02-172026-02-17
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2026
Medtronic plc (Exact name of Registrant as Specified in its Charter)
Ireland 1-36820 98-1183488 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) +353 1 438-1700 (Registrant’s telephone number, including area code)
Not Applicable Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange 1.125% Senior Notes due 2027MDT/27New York Stock Exchange 0.375% Senior Notes due 2028MDT/28New York Stock Exchange 3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange 3.650% Senior Notes due 2029MDT/29New York Stock Exchange 2.950% Senior Notes due 2030MDT/30New York Stock Exchange 1.625% Senior Notes due 2031MDT/31New York Stock Exchange 1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange 3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange 0.750% Senior Notes due 2032MDT/32New York Stock Exchange 3.375% Senior Notes due 2034MDT/34New York Stock Exchange 3.875% Senior Notes due 2036MDT/36New York Stock Exchange 2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange 1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange 1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange 4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange 4.200% Senior Notes due 2045MDT/45New York Stock Exchange 1.750% Senior Notes due 2049MDT/49New York Stock Exchange 1.625% Senior Notes due 2050MDT/50New York Stock Exchange 4.150% Senior Notes due 2053MDT/53New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition
On February 17, 2026, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its third quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01.Exhibits.
(d) List of Exhibits Exhibit Number Description
99.1 Press release of Medtronic plc, dated February 17, 2026
104Cover Page Interactive Data File (embedded with th
Nov 18, 2025
mdt-202511180001613103H91 VY19false00016131032025-11-182025-11-180001613103mdt:A1.125SeniorNotesDue2027Member2025-11-182025-11-180001613103mdt:A0.375SeniorNotesDue2028Member2025-11-182025-11-180001613103mdt:A3.000SeniorNotesDue2028Member2025-11-182025-11-180001613103mdt:A3.650SeniorNotesDue2029Member2025-11-182025-11-180001613103mdt:A2.950SeniorNotesDue2030Member2025-11-182025-11-180001613103mdt:A1.625SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A1.000SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A3.125SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A0.750SeniorNotesDue2032Member2025-11-182025-11-180001613103mdt:A3.375SeniorNotesDue2034Member2025-11-182025-11-180001613103mdt:A3.875SeniorNotesDue2036Member2025-11-182025-11-180001613103mdt:A2.250SeniorNotesDue2039Member2025-11-182025-11-180001613103mdt:A1.500SeniorNotesDue2039Member2025-11-182025-11-180001613103mdt:A1.375SeniorNotesDue2040Member2025-11-182025-11-180001613103mdt:A4.150SeniorNotesDue2043Member2025-11-182025-11-180001613103mdt:A4.200SeniorNotesDue2045Member2025-11-182025-11-180001613103mdt:A1.750SeniorNotesDue2049Member2025-11-182025-11-180001613103mdt:A1.625SeniorNotesDue2050Member2025-11-182025-11-180001613103mdt:A4.150SeniorNotesDue2053Member2025-11-182025-11-18
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2025
Medtronic plc (Exact name of Registrant as Specified in its Charter)
Ireland 1-36820 98-1183488 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) +353 1 438-1700 (Registrant’s telephone number, including area code)
Not Applicable Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange 1.125% Senior Notes due 2027MDT/27New York Stock Exchange 0.375% Senior Notes due 2028MDT/28New York Stock Exchange 3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange 3.650% Senior Notes due 2029MDT/29New York Stock Exchange 2.950% Senior Notes due 2030MDT/30New York Stock Exchange 1.625% Senior Notes due 2031MDT/31New York Stock Exchange 1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange 3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange 0.750% Senior Notes due 2032MDT/32New York Stock Exchange 3.375% Senior Notes due 2034MDT/34New York Stock Exchange 3.875% Senior Notes due 2036MDT/36New York Stock Exchange 2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange 1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange 1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange 4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange 4.200% Senior Notes due 2045MDT/45New York Stock Exchange 1.750% Senior Notes due 2049MDT/49New York Stock Exchange 1.625% Senior Notes due 2050MDT/50New York Stock Exchange 4.150% Senior Notes due 2053MDT/53New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition
On November 18, 2025, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its second quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01.Exhibits.
(d) List of Exhibits Exhibit Number Description
99.1 Press release of Medtronic plc, dated November 18, 2025
104Cover Page Interactive Data File (embedded with t
Aug 19, 2025
mdt-202508180001613103H91 VY19false00016131032025-08-182025-08-180001613103us-gaap:CommonStockMember2025-08-182025-08-180001613103mdt:A0.000SeniorNotesDue2025Member2025-08-182025-08-180001613103mdt:A2.625SeniorNotesDue2025Member2025-08-182025-08-180001613103mdt:A1.125SeniorNotesDue2027Member2025-08-182025-08-180001613103mdt:A0.375SeniorNotesDue2028Member2025-08-182025-08-180001613103mdt:A3.000SeniorNotesDue2028Member2025-08-182025-08-180001613103mdt:A3.650SeniorNotesDue2029Member2025-08-182025-08-180001613103mdt:A1.625SeniorNotesDue2031Member2025-08-182025-08-180001613103mdt:A1.000SeniorNotesDue2031Member2025-08-182025-08-180001613103mdt:A3.125SeniorNotesDue2031Member2025-08-182025-08-180001613103mdt:A0.750SeniorNotesDue2032Member2025-08-182025-08-180001613103mdt:A3.375SeniorNotesDue2034Member2025-08-182025-08-180001613103mdt:A3.875SeniorNotesDue2036Member2025-08-182025-08-180001613103mdt:A2.250SeniorNotesDue2039Member2025-08-182025-08-180001613103mdt:A1.500SeniorNotesDue2039Member2025-08-182025-08-180001613103mdt:A1.375SeniorNotesDue2040Member2025-08-182025-08-180001613103mdt:A4.150SeniorNotesDue2043Member2025-08-182025-08-180001613103mdt:A1.750SeniorNotesDue2049Member2025-08-182025-08-180001613103mdt:A1.625SeniorNotesDue2050Member2025-08-182025-08-180001613103mdt:A4.150SeniorNotesDue2053Member2025-08-182025-08-18
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2025
Medtronic plc (Exact name of Registrant as Specified in its Charter)
Ireland 1-36820 98-1183488 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) +353 1 438-1700 (Registrant’s telephone number, including area code)
Not Applicable Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange 0.000% Senior Notes due 2025MDT/25ANew York Stock Exchange 2.625% Senior Notes due 2025MDT/25BNew York Stock Exchange 1.125% Senior Notes due 2027MDT/27New York Stock Exchange 0.375% Senior Notes due 2028MDT/28New York Stock Exchange 3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange 3.650% Senior Notes due 2029MDT/29New York Stock Exchange 1.625% Senior Notes due 2031MDT/31New York Stock Exchange 1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange 3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange 0.750% Senior Notes due 2032MDT/32New York Stock Exchange 3.375% Senior Notes due 2034MDT/34New York Stock Exchange 3.875% Senior Notes due 2036MDT/36New York Stock Exchange 2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange 1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange 1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange 4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange 1.750% Senior Notes due 2049MDT/49New York Stock Exchange 1.625% Senior Notes due 2050MDT/50New York Stock Exchange 4.150% Senior Notes due 2053MDT/53New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition
On August 19, 2025, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its first quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangemen
This page provides Medtronic plc. (MDT) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on MDT's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.